Guest guest Posted November 9, 2007 Report Share Posted November 9, 2007 Defective Drug Newsletter - November 2007- Providing Information on Controversial DrugsFeatured Stories Doctors Warned and Trasylol Clinical Trial Halted- October 26, 2007The clinical trial for Bayer AG's heart medication, Trasylol, has been put on hold after new risks were reported in relation to the drug. The drug has recently been linked to serious bleeding and deaths caused by hemorrhage.read full article Child Cold Medicines Reportedly Ineffective and Dangerous- October 24, 2007 A panel of advisors for the Food and Drug Administration (FDA) voted last week to ban several over-the-counter cough and cold medicines that are catered towards children. Many studies have not only failed to prove that drugs are effective, but an increased amount of studies have shown that they have obvious dangers. read full article Infant Cold Medicines Recalled- October 15, 2007Novartis and Prestige Brands Holdings have recalled their oral infant medicines after data showed that the cough and cold medications were being improperly used. CVS Caremark Corp. has removed the nonprescription medicines from its shelves and company officials claim that customers who purchased the drugs from their store can return them for a full refund. read full article Increase in Children's Use of Heartburn Drugs- October 11, 2007Researchers claim that the prescription use among children has increased 56 percent in recent years and they believe this medication use could be contributing to the increase in obesity cases in kids. Doctors claim that heartburn is a common complication of being overweight and the increase in children taking heartburn medications happened at the time of the nation's rising obesity epidemic. read full article FDA Investigates Deaths Tied to Ultrasound Drugs- October 8, 2007The Food and Drug Administration is looking into reports of death and serious heart reactions in patients who were given one of two drugs, Definity or Optison, to enhance ultrasound imaging prior to an echocardiography (ECG).read full article If you have any questions, concerns or comments regarding this newsletter please contact us.Consumer Drug Safety FDA Launches Drug Safety NewsletterThis fall the Food and Drug Administration launched a new publication to provide information regarding drug safety. Though the newsletter is primarily intended for healthcare professionals, it is available to anyone who wishes to .One of the primary goals of the agency’s newsletter is to raise awareness about adverse events and promote the reporting of such events . The FDA receives over 400,000 reports of drug-related events every year, and it is this information that helps the agency identify drug risks and inform the public.Read More... Drug with Side Effects Ask A Legal QuestionAre you concerned about a drug you are currently taking? Would you like expert advice on your legal rights regarding a particular drug? Free Legal Consultation. Counterfeit Drugs Battle to Prevent Fake Drugs On ShelvesSome of the world's top pharmaceutical companies are currently experimenting with new technologies in hopes of preventing phony drugs from hitting the market and harming consumers. The counterfeit drug issue came to light for one major pharmaceutical company, Johnson & Johnson when phony diabetes test strips hit the shelves of pharmacies across the country under their name. Read More... -------------- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.